Skip to main content
SpringerLink
Log in

1-MT enhances potency of tumor cell lysate-pulsed dendritic cells against pancreatic adenocarcinoma by downregulating the percentage of tregs

  • Published:
Journal of Huazhong University of Science and Technology [Medical Sciences] Aims and scope Submit manuscript

Summary

This study examined whether 1-methyl-tryptophan [1-MT, an indoleamine 2, 3-dioxygenase (IDO) inhibitor] could reduce CD4+CD25+ regulatory T cells (Tregs) proliferation and improve the anti-tumor efficacy of dendritic cells (DCs) pulsed with tumor cell lysate in the mice bearing pancreatic adenocarcinoma. The models of pancreatic adenocarcinoma were established in C57BL/6 mice by subcutaneous injection of Pan02 cells. Eight mice which were subcutaneously injected with PBS served as control. The expression of IDO was determined in tumor draining lymph nodes (TDLNs) and spleens of the murine pancreatic adenocarcinoma models. The prevalence of Tregs was measured in the TDLNs and spleens before and after 1-MT administration. The dendritic cells were pulsed with tumor cell lysate for preparing DC vaccine. The DC vaccine, as a single agent or in combination with 1-MT, was administered to pancreatic adenocarcinoma mice. The anti-tumor efficacy was determined after different treatments by regular observation of tumor size. The results showed that the levels of IDO mRNA and protein in tumor-bearing mice were significantly higher than those in the normal control mice. The percentage of Tregs in the spleen and TDLNs was also higer in tumor-bearing mice than in normal control mice (P<0.05). Foxp3 expression was significantly lower in the TDLNs and spleens of tumor-bearing mice administrated with 1-MT than that in normal control mice. Furthemore, in the mice that were administered 1-MT plus DC vaccine, the tumor was increased more slowly than in mice treated with DC vaccine or 1-MT alone, or PBS on day 36 (P<0.01). Our results indicated that 1-MT may enhance anti-tumor efficacy of dendritic cells pulsed with tumor cell lysate by downregulating the percentage of Tregs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Itoh K, Yamada A, Mine T, et al. Recent advances in cancer vaccines: an overview. Jpn J Clin Oncol, 2009, 39(2):73–80

    Article  PubMed  Google Scholar 

  2. Gilboa E. DC-based cancer vaccines. J Clin Invest, 2007,117(5):1195–203

    Article  CAS  PubMed  Google Scholar 

  3. Schadendorf D, Ugurel S, Schuler-Thurner B, et al. Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG. Ann Oncol, 2006,17(4):563–570

    Article  CAS  PubMed  Google Scholar 

  4. Qiu J, Li GW, Sui YF, et al. Heat-shocked tumor cell lysate-pulsed dendritic cells induce effective anti-tumor immune response in vivo. World J Gastroenterol, 2006,12(3):473–478

    CAS  PubMed  Google Scholar 

  5. Ohshita A, Yamaguchi Y, Minami K, et al. Generation of tumor-reactive effect or lymphocytes using tumor RNA-introduced dendritic cells in gastric cancer patients. Int J Oncol, 2006,28(5):1163–1171

    CAS  PubMed  Google Scholar 

  6. Dohnal AM, Graffi S, Witt V, et al. Comparative evaluation of techniques for the manufacturing of dendritic cell-based cancer vaccines. J Cell Mol Med, 2009,13(1):125–135

    Article  CAS  PubMed  Google Scholar 

  7. Oh ST, Kim CH, Park MY, et al. Dendritic cells transduced with recombinant adenoviruses induce more efficient anti-tumor immunity than dendritic cells pulsed with peptide. Vaccine, 2006,24(15):2860–2868

    Article  CAS  PubMed  Google Scholar 

  8. David J, Bettinga XM, Kafia K, et al. Enhanced immune stimulation by a therapeutic lymphoma tumor antigen vaccine produced in insect cells involves mannose receptor targeting to antigen presenting cells. Vaccine, 2009, 27:250–259

    Google Scholar 

  9. Liu XQ, Wang X. Indoleamine 2,3-dioxygenase in tumor induced tolerance. Chin Med J (Engl), 2009, 122(24):3072–3027

    CAS  Google Scholar 

  10. Lob S, Konigsrainer A. Is IDO a key enzyme bridging the gap between tumor escape and tolerance induction? Langenbecks Arch Surg, 2008,393(6): 995–1003

    Article  PubMed  Google Scholar 

  11. Sakaguchi, Wing K, Onishi Y, et al. Regulatory T cells: how do they suppress immune responses? Int Immunol, 2009,21(10):1105–1111

    Article  CAS  PubMed  Google Scholar 

  12. Munn DH, Zhou M, Attwood JT, et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science, 1998,281(5380):1191–1193

    Article  CAS  PubMed  Google Scholar 

  13. Hayashi T, Beck L, Rossetto C, et al. Inhibition of experimental asthma by indoleamine 2,3-dioxygenase. J Clin Invest, 2004,114(2):270–279

    CAS  PubMed  Google Scholar 

  14. Kwidzinski E, Bunse J, Aktas O, et al. Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation. FASEB J, 2005,19(10):1347–1349

    CAS  PubMed  Google Scholar 

  15. Grohmann U, Orabona C, Fallarino F, et al. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol, 2002,3(11): 1097–1101

    Article  CAS  PubMed  Google Scholar 

  16. Yu G, Fang M, Gong M, et al. Steady state dendritic cells with forced IDO expression induce skin allograft tolerance by upregulation of regulatory T cells. Transpl Immunol, 2008,18(3):208–219

    Article  CAS  PubMed  Google Scholar 

  17. Mellor AL, Munn DH. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol, 2004,4(10):762–774

    CAS  Google Scholar 

  18. Grohmann U, Fallarino F, Puccetti P. Tolerance, DCs and tryptophan: much ado about IDO. Trends Immunol, 2003,24(5): 242–248

    Article  CAS  PubMed  Google Scholar 

  19. Puccetti P, Fallarino F. Generation of T cell regulatory activity by plasmacytoid dendritic cells and tryptophan catabolism. Blood Cells Mol Dis, 2008,40(1): 101–105

    Article  CAS  PubMed  Google Scholar 

  20. Belladonna ML, Orabona C, Grohmann U, et al. TGF-beta and kynurenines as the key to infectious tolerance. Trends Mol Med, 2009,15(2):41–49

    Article  CAS  PubMed  Google Scholar 

  21. Dannull J, Su Z, Rizzieri D, et al. Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. J Clin Invest, 2005,115(12):3623–3633

    Article  CAS  PubMed  Google Scholar 

  22. Wilczynski JR, Radwan M, Kalinka J. The characterization and role of regulatory T cells in immune reactions. Front Biosci, 2008,13: 2266–2274

    Article  CAS  PubMed  Google Scholar 

  23. Moo-Young TA, Larson JW, Belt BA, et al. Tumor-derived TGF-beta mediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancer. J Immunother, 2009,32(1):12–21

    Article  CAS  PubMed  Google Scholar 

  24. Andersson J, Tran DQ, Pesu M, et al. CD4+FoxP3+ regulatory T cells confer infectious tolerance in a TGF-ta-dependent manner. J Exp Med, 2008, 205(9):1975–1981

    Google Scholar 

  25. Liu Y, Zhang P, Li J, et al. A critical function for TGF-[beta] signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells. Nat Immunol, 2008,9(6):632

    Article  CAS  PubMed  Google Scholar 

  26. Huber S, Stahl FR, Schrader J, et al. Activin a promotes the TGF-ta-induced conversion of CD4+CD25− T cells into Foxp3+ induced regulatory T cells. J Immunol, 2009,182(8):4633–4640

    Google Scholar 

  27. Belladonna ML, Volpi C, Bianchi R, et al. Cutting edge: Autocrine TGF-ta sustains default tolerogenesis by IDO-competent dendritic cells. J Immunol, 2008,181(8):5194–5198

    Google Scholar 

  28. Ou X, Cai S, Liu P, et al. Enhancement of dendritic cell-tumor fusion vaccine potency by indoleaminepyrrole 2,3-dioxygenase inhibitor, 1-MT. J Cancer Res Clin Oncol, 2008,134:525–533

    Article  CAS  PubMed  Google Scholar 

  29. Fallarino F, Grohmann U, You S, et al. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J Immunol, 2006,176(11): 6752–6761

    CAS  PubMed  Google Scholar 

  30. Sharma MD, Baban B, Chandler P, et al. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine ioxygenase. J Clin Invest, 2007,117(9):2570–2582

    Article  CAS  PubMed  Google Scholar 

  31. Ziske C, Etzrodt PE, Eliu AS, et al. Increase of in vivo antitumoral activity by CD40l (CD154) gene transfer into pancreatic tumor cell-dendritic cell hybrids. Pancreas, 2009,38(10):758–765

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pancreatic Surgery Center of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China

    Yuandong Li  (李元栋), Jun Xu  (徐 钧), Haojun Zou  (邹浩军) & Chunyou Wang  (王春友)

Authors
  1. Yuandong Li  (李元栋)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jun Xu  (徐 钧)
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Haojun Zou  (邹浩军)
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chunyou Wang  (王春友)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chunyou Wang  (王春友).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, Y., Xu, J., Zou, H. et al. 1-MT enhances potency of tumor cell lysate-pulsed dendritic cells against pancreatic adenocarcinoma by downregulating the percentage of tregs. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 30, 344–348 (2010). https://doi.org/10.1007/s11596-010-0354-3

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-010-0354-3

Key words

Search

Navigation